Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Platelet Sequestration Patterns and Clearance Rates in Patients with ITP Compared to Healthy Individuals

Vivianne S. Nelson, Marina Kartachova, Sufia N. Amini, Masja De Haas, Martin R. Schipperus, Rick Kapur, Tanja Netelenbos

Blood (2024) 144 (Supplement 1): 3950.

https://doi.org/10.1182/blood-2024-202962

Published: 2024

Journal Articles

The ‘Stop TPO-Receptor Agonist in ITP Patients’ (STIP) Study: Clinical and Immune Modulatory Effects of Romiplostim Tapering

Vivianne S. Nelson, Sufia N. Amini, Tanja Netelenbos, Marina Kartachova, Roger EG Schutgens, Otto Visser, Peter E. Westerweel, Jaap Jan Zwaginga, Suzanne Hofstede-Van Egmond, Rick Kapur, Masja De Haas, Leendert Porcelijn, Martin R. Schipperus

Blood (2024) 144 (Supplement 1): 2554.

https://doi.org/10.1182/blood-2024-203223

Published: 2024

Journal Articles

Effect of Change in Haemoglobin Mass on Physiology in Anaemic and Non-Anaemic Subjects: An Umbrella Review

Rik Tonino, Lisa Zwaginga, Martin R. Schipperus, Jaap Jan Zwaginga

Blood (2022) 140 (Supplement 1): 13138–13140.

https://doi.org/10.1182/blood-2022-163292

Published: 2022

Journal Articles

Perioperative Eltrombopag or Intravenous Immune Globulin for Patients with Immune Thrombocytopenia: A Multicenter Randomized Trial

Donald M. Arnold, MD, Nancy Heddle, MSc, Richard Cook, Cyrus C. Hsia, MDBSc,FRCPC, Mark Blostein, MDFRCPC, Erin Jamula, MSc, Michelle Sholzberg, MDBSc,FRCPC,MSc, Yulia Lin, MD, Jeannine Kassis, MD, Loree Larratt, MD FRCP(C), Sufia Amini, MD, Martin R. Schipperus, Wendy Lim, MD MSc, Prakash Vishnu, MD, Margaret Warner, FRCPC, Julie Carruthers, MLT, B.Com(Hon), Shannon J Lane, MPH, Na Li, PhD, John G. Kelton, MD

Blood (2019) 134 (Supplement_1): 896.

https://doi.org/10.1182/blood-2019-122609

Published: 2019

Journal Articles

Hyper-Sialylated IgG M254, an Innovative Therapeutic Candidate, Evaluated in Healthy Volunteers and in Patients with Immune Thrombocytopenia Purpura: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics

Santiago Arroyo, MD PhD, Renger G Tiessen, MD, William S Denney, PhD, Jim Jin, MS, Mattheus Paulus (Thijs) van Iersel, MD, Heidi Zeitz, MD CCRA, Anthony M Manning, PhD, Martin R. Schipperus, MD PhD, James B. Bussel, MD

Blood (2019) 134 (Supplement_1): 1090.

https://doi.org/10.1182/blood-2019-125993

Published: 2019

Journal Articles

Results of Autologous and Allogeneic Transplantation in Patients with Primary Plasma Cell Leukemia: A Large Retrospective Analysis of the Chronic Malignancies Working Party of the EBMT

Blood (2018) 132 (Supplement 1): 3425.

https://doi.org/10.1182/blood-2018-99-113824

Published: 2018

Journal Articles

Sequestration Pattern in ITP Liver/Spleen Scan Correlates with the Presence of Anti-Glycoprotein V Antibodies in ITP Patients

Sufia N. Amini, MD, Annemieke Sobels, MSc, Christianne Duchateau, MD, Masja De Haas, MD PhD, Leendert Porcelijn, MD, Roger Schutgens, MD PhD, Jaap Jan Zwaginga, MD PhD, Martin R. Schipperus, MD PhD

Blood (2017) 130 (Supplement 1): 1046.

https://doi.org/10.1182/blood.V130.Suppl_1.1046.1046

Published: 2017

Journal Articles

Efficacy and Safety of First-Line Therapy with Chlorambucil, Rituximab and Individualized Dose Lenalidomide in FCR-Unfit Patients with Advanced Chronic Lymphocytic Leukemia (CLL): A Phase I/II HOVON Trial

Blood (2017) 130 (Supplement 1): 4328.

https://doi.org/10.1182/blood.V130.Suppl_1.4328.4328

Published: 2017

Journal Articles

Clofarabin Added to Standard Treatment in Adult Patients with Newly Diagnosed ALL: First Results of the Randomized Phase III HOVON-100 Study

Blood (2017) 130 (Supplement 1): 2606.

https://doi.org/10.1182/blood.V130.Suppl_1.2606.2606

Published: 2017

Journal Articles

Detection of Platelet Autoantibodies Revisited to Identify Immune Thrombocytopenia

Leendert Porcelijn, MD, Elly Huiskes, Gonda Oldert, Rob Fijnheer, MD PhD, Martin R. Schipperus, MD PhD, Jaap Jan Zwaginga, MD PhD, Masja De Haas, Prof, MD

Blood (2015) 126 (23): 1142.

https://doi.org/10.1182/blood.V126.23.1142.1142

Published: 2015

Journal Articles

Bortezomib Maintenance Therapy after Induction with R-CHOP, ARA-C and Autologous Stem Cell Transplantation in Newly Diagnosed MCL Patients, Results of a Multicenter Phase II HOVON Study

Jeanette K Doorduijn, MD PhD, Monique C. Minnema, MD PhD, Marie Jose Kersten, MD PhD, Pieternella J Lugtenburg, MD PhD, Martin R. Schipperus, MD PhD, Marinus van Marwijk Kooy, MD PhD, Marius MacKenzie, MD PhD, Josée M Zijlstra, MD, Henriette W Berenschot, MD, M. R Schaafsma, MD PhD, Dana A Chitu, PhD, Hanneke C. Kluin-Nelemans, MD PhD

Blood (2015) 126 (23): 339.

https://doi.org/10.1182/blood.V126.23.339.339

Published: 2015

Journal Articles

Very Good Response and Overall Survival after Allogeneic Stem Cell Transplantation in Patients with Systemic Light Chain Amyloidosis; Results of a Non-Interventional Study By the Plasma Cell Disorder Subcommittee of the Chronic Malignancy Working Party of the EBMT

Stefan Schönland, Ute Hegenbart, MD, Simona Iacobelli, Jennifer Hoek, Jakob R. Passweg, MD, Dominique Bordessoule, Jean-Henri Bourhis, MD PhD, Martin R. Schipperus, MD PhD, Theo deWitte, Laurent Garderet, MD, Nicolaus Kröger

Blood (2015) 126 (23): 4397.

https://doi.org/10.1182/blood.V126.23.4397.4397

Published: 2015

Journal Articles

Health-Related Quality of Life (HRQoL) in Patients (Pts) with Chronic Immune Thrombocytopenic Purpura (ITP): Results from Two Placebo-Controlled Phase 3 Studies of AMG 531.

James N. George, Roger Lyons, Francis J. Cuevas, Ronald S. Go, David H. Henry, Robert L. Redner, Lawrence Rice, Martin R. Schipperus, Susan D. Mathias, Sue Gao, Matthew Guo, Janet L. Nichol

Blood (2007) 110 (11): 1314.

https://doi.org/10.1182/blood.V110.11.1314.1314

Published: 2007

Journal Articles

Long-Term Dosing of AMG 531 Is Effective and Well Tolerated in Thrombocytopenic Patients with Immune Thrombocytopenic Purpura.

James B. Bussel, David J. Kuter, James N. George, Louis M. Aledort, Alan E. Lichtin, Roger M. Lyons, Jorge Nieva, Jeffrey S. Wasser, Emanuelle Bourgeois, Mies Kappers-Klunne, Francois LeFrere, Martin R. Schipperus, Reggie Kelly, Jenny Christal, Chien-Feng Chen, Janet L. Nichol

Blood (2005) 106 (11): 220.

https://doi.org/10.1182/blood.V106.11.220.220

Published: 2005

Journal Articles

An Open-Label, Unit Dose-Finding Study Evaluating the Safety and Platelet Response of a Novel Thrombopoietic Protein (AMG531) in Thrombocytopenic Adult Patients (Pts) with Immune Thrombocytopenic Purpura (ITP).

Adrian Newland, MD, Marie T. Caulier, MD, Martin R. Schipperus, MD, Maria Kappers-Klunne, MD, Bruno R. Varet, Karen Watkins, BA, Chien-Feng Chen, PhD, Janet L. Nichol, MS

Blood (2004) 104 (11): 2058.

https://doi.org/10.1182/blood.V104.11.2058.2058

Published: 2004

NARROW

Platelet Sequestration Patterns and Clearance Rates in Patients with ITP Compared to Healthy Individuals

The ‘Stop TPO-Receptor Agonist in ITP Patients’ (STIP) Study: Clinical and Immune Modulatory Effects of Romiplostim Tapering

Effect of Change in Haemoglobin Mass on Physiology in Anaemic and Non-Anaemic Subjects: An Umbrella Review

Perioperative Eltrombopag or Intravenous Immune Globulin for Patients with Immune Thrombocytopenia: A Multicenter Randomized Trial

Hyper-Sialylated IgG M254, an Innovative Therapeutic Candidate, Evaluated in Healthy Volunteers and in Patients with Immune Thrombocytopenia Purpura: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics

Results of Autologous and Allogeneic Transplantation in Patients with Primary Plasma Cell Leukemia: A Large Retrospective Analysis of the Chronic Malignancies Working Party of the EBMT

Sequestration Pattern in ITP Liver/Spleen Scan Correlates with the Presence of Anti-Glycoprotein V Antibodies in ITP Patients

Efficacy and Safety of First-Line Therapy with Chlorambucil, Rituximab and Individualized Dose Lenalidomide in FCR-Unfit Patients with Advanced Chronic Lymphocytic Leukemia (CLL): A Phase I/II HOVON Trial

Clofarabin Added to Standard Treatment in Adult Patients with Newly Diagnosed ALL: First Results of the Randomized Phase III HOVON-100 Study

Detection of Platelet Autoantibodies Revisited to Identify Immune Thrombocytopenia

Bortezomib Maintenance Therapy after Induction with R-CHOP, ARA-C and Autologous Stem Cell Transplantation in Newly Diagnosed MCL Patients, Results of a Multicenter Phase II HOVON Study

Very Good Response and Overall Survival after Allogeneic Stem Cell Transplantation in Patients with Systemic Light Chain Amyloidosis; Results of a Non-Interventional Study By the Plasma Cell Disorder Subcommittee of the Chronic Malignancy Working Party of the EBMT

Health-Related Quality of Life (HRQoL) in Patients (Pts) with Chronic Immune Thrombocytopenic Purpura (ITP): Results from Two Placebo-Controlled Phase 3 Studies of AMG 531.

Long-Term Dosing of AMG 531 Is Effective and Well Tolerated in Thrombocytopenic Patients with Immune Thrombocytopenic Purpura.

An Open-Label, Unit Dose-Finding Study Evaluating the Safety and Platelet Response of a Novel Thrombopoietic Protein (AMG531) in Thrombocytopenic Adult Patients (Pts) with Immune Thrombocytopenic Purpura (ITP).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only